Cytochrome P450-catalyzed oxidation of halobenzene derivatives

Chemical Research in Toxicology

Volumn 10, Issue 6, 1997, Pages 629-635

  Rietjens, Ivonne M C M ^a   Besten, Cathaline Den ^b   Hanzlik, Robert P ^c   Van Bladeren, Peter J ^a,d  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

^c UNIVERSITY OF KANSAS   (United States)

^d TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON; BENZENE DERIVATIVE; BENZOQUINONE DERIVATIVE; CYTOCHROME P450; EPOXIDE; HALOCARBON; PHENOL DERIVATIVE; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;

ALKYLATION; DEHALOGENATION; HALOGENATION; INTOXICATION; LIVER MICROSOME; LIVER TOXICITY; OXIDATION; REVIEW; XENOBIOTIC METABOLISM;

ALKYLATION; ANIMALS; BENZENE DERIVATIVES; BENZOQUINONES; BROMOBENZENES; CYTOCHROME P-450 ENZYME SYSTEM; EPOXY COMPOUNDS; FUNGICIDES, INDUSTRIAL; HEXACHLOROBENZENE; OXIDATION-REDUCTION; QUINONES; RATS;

EID: 0030913482     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx9601061     Document Type: Review

References (53)

1. Lau, S. S., Abrams, G. D., and Zannoni, V. G. (1980) Metabolic activation and detoxification of hromobenzene leading to cytotoxicity. J. Pharmacol. Exp. Ther. 213, 703-708.
2. Brodie, B. B., Reid, W. D., Cho, A. K., Sipes, G., and Gillette, J. R. (1971) Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Natl. Acad. Sci. U.S.A. 68, 160-164.
3. Jollow, D. J., Mitchell, J. R., Zampaglione, N., and Gilette, J. R. (1974) Bromobenzene-induced liver necrosis: Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11, 151-160.
4. Monks, T. J., Hinson, J. A., and Gillette, J. R. ( 1982) Bromobenzene and p-bromophenol toxicity and covalent binding in vivo. Life Sci. 30, 841-848.
5. Den Besten, C., Peters, M. M. C. G., and Van Bladeren, P. J. (1989) The metabolism of pentachlorobenzene by rat liver microsomes: the nature of the reactive intermediates formed. Biochem. Biophys. Res. Commun. 163, 1275-1281.
6. Van Ommen, B., Adang, A. E. P., Brader, L., Posthumus, M. A., Müller, F., and Van Bladeren, P. J. (1986) The microsomal metabolism of hexachlorobenzene. Origin of the covalent binding to protein. Biochem. Pharmacol. 35, 3233-3238.
7. Van Ommen, B., Adang, A. E. P., Müller, F., and Van Bladeren, P. J. (1986) The microsomal metabolism of pentachlorophenol and its covalent binding to protein and DNA. Chem. Biol. Interact. 60, 1-11.
8. Van Ommen, B., and Van Bladeren, P. J. (1989) Possible reactive intermediates in the oxidative biotransformation of hexachlorobenzene. Drug Metab. Drug. Interact. 7, 213-243.
9. Jerina, D. M., and Daly, J. W. ( 1974) Arene oxides: A new aspect of drug metabolism. Science 185, 573-582.
10. Daly, J. W., Jerina, D. M., and Witkop, B. (1972) Arene oxides and the NIH shift: The metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia 28, 1129-1264.
11. Van Ommen, B., Voncken, J. W., Müller, F., and Van Bladeren, P. J. (1988) The oxidation of tetrachloro-1,4-hydroquinone by microsomes and purified cytochrome P450b. Implications for covalent binding to protein and involvement of reactive oxygen species. Chem. Biol. Interact. 65, 247-259.
12. Gant, T. W., Rao, D. N. R., Mason, R. P., and Cohen, G. M. (1988) Redox cycling and sulphydryl arylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. Chem. Biol. Interact. 65, 157-173.
13. Powis, G., Hodnett, E. M., Santone, K. S., See, K. L., and Melder, D. C. (1987) Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines. Cancer Res. 47, 2363-2370.
14. Rossi, L., Moore, G. A., Orrenius, S., and O'Brien, P. J. (1986) Quinone toxicity in hepatocytes without oxidative stress. Arch. Biochem. Biophys. 251, 25-35.
15. Den Besten, C., Smink, M. C. C., De Vries, E. J., and Van Bladeren, P. J. (1991) Metabolic activation of 1,2,4-trichlorobenzene and pentachlorobenzene by rat liver microsomes: A major role for quinone metabolites. Toxicol. Appl. Pharmacol. 108, 223-233.
16. Monks, T. J., and Lau, S. S. (1990) Nephrotoxicity of quinol/ quinone-linked S-conjugates. Toxicol. Lett. 53, 59-67.
17. Guengerich, F. P., and Liebler, D. C. (1985) Enzymatic activation of chemicals to toxic metabolites. CRC Crit. Rev. Toxicol. 14, 259-307.
18. Guengerich, F. P., and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes. Chem. Res. Toxicol. 4, 391-405.
19. Den Besten, C., Ellenbroek, E., Van der Ree, M. A. E., Rietjens, I. M. C. M., and Van Bladeren, P. J. (1992) The involvement of primary and secondary metabolism in the covalent binding of 1,2- and 1,4-dichlorobenzenes. Chem. Biol. Interact. 84, 259-275.
20. Weller, P. E., and Hanzlik, R. P. (1991) Isolation of S-(bromophenyl)cysteine isomers from liver proteins of bromobenzene treated rats. Chem. Res. Toxicol. 4, 17-20.
21. Slaughter, D. E., and Hanzlik, R. P. (1991) Indentification of epoxide-and quinone-derived bromobenzene adducts to protein sulfur nucleophiles. Chem. Res. Toxicol. 4, 349-359.
22. Monks, T. J., Pohl, J. R., Gilette, M., Hong, M., Highet, R. J., Ferretti, J. A., and Hinson, J. A. (1982) Stereoselective formation of bromobenzene glutathione conjugates. Chem. Biol. Interact. 41, 203-216.
23. Docks, E. L., and Krishna, G. (1975) Covalent binding of transstilbene to rat liver microsomes. Biochem. Pharmacol. 24, 1965-1969.
24. Holme, J. A., Hongslo, J. K., Björge, C., and Nelson, S. D. (1991) Comparative cytotoxic effects of acetaminophen (N-acetyl-p-aminophenol), a non-hepatotoxic regioisomer acetyl-m-aminophenol and their postulated reactive hydroquinone and quinone metabolites in monolayer cultures of mouse hepatocytes. Biochem. Pharmacol. 42, 1137-1142.
25. Gillette, J. R. (1974) A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactive metabolites with changes in the incidence and severity of toxicity. Biochem. Pharmacol. 23, 2785-2794.
26. Gillette, J. R. (1974) A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. II. Alterations in the kinetics of covalent binding. Biochem. Pharmacol. 23, 2927-2938.
27. Ahlborg, U. A., Larsson, K., and Thumber, T. (1978) Metabolism of pentachlorophenol in vivo and in vitro. Arch. Toxicol. 40, 45-53.
28. Renner, G., and Hopfer, C. (1990) Metabolic studies on pentachlorophenol (PCP) in rats. Xenobiotica 10, 573-582.
29. Mico, B. A., Branchflower, R. V., Pohl, L. R., Pudzianowski, A. T., and Loew, G. H. (1982) Oxidation of carbon tetrachloride, bromotrichloromethane, and carbon tetrabromide by rat liver microsomes to electrophilic halogens. Life Sci. 30, 131-137.
30. Rizk, P. N., and Hanzlik, R. P. (1995) Oxidative and non-oxidative metabolism of 4-iodoanisole by rat liver microsomes. Xenobiotica 25, 143-150.
31. Goeptar, A. R., Te Koppele, J. M., Van Maanen, J. M. S., Zoetemelk, C. E. M., and Vermeulen, N. P. E. (1992) One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450. Biochem. Pharmacol. 43, 343-352.
32. Den Besten, C., Van Bladeren, P. J., Duizer, E., Vervoort, J., and Rietjens, I. M. C. M. (1993) Cytochrome P450-mediated oxidation of pentafluorophenol to tetrafluorobenzoquinone as the primary reaction product. Chem. Res. Toxicol. 6, 674-680.
33. Rietjens, I. M. C. M., Tyrakowska, B., Veeger, C., and Vervoort, J. (1990) Reaction pathways for biodehalogenation of fluorinated anilines. Eur. J. Biochem. 194, 945-954.
34. Rietjens, I. M. C. M., and Vervoort, J. (1991) Bioactivation of 4-fluorinated anilines to benzoquinoneimines as primary reactive products. Chem. Biol. Interact. 77, 263-281.
35. Ohe, T., Mashino, T., and Hirobe, M. (1995) Novel oxidative pathway of para-substituted phenols in cytochrome P450 chemical model: substituent elimination accompanying ipso-substitution by the oxygen atom of the active species. Tetrahedron Lett. 36, 7681-7684.
36. Cnubben, N. H. P., Vervoort, J., Boersma, M. G., and Rietjens, I. M. C. M. (1995) The effect of varying halogen substituent patterns on the cytochrome P450 catalysed dehalogenation of 4-halogenated anilines to 4-aminophenol metabolites. Biochem. Pharmacol. 49, 1235-1248.
37. Hecht, S. S., LaVoie, E. J., Bedenko, V., Pingaro, L., Katayama, S., Hoffmann, D., Sardella, D. J., Boger, E., and Lehr, R. E. (1981) Reduction of tumorigenicity and of dihydrodiol formation by fluorine substitution in the angular rings of dibenzo(a,i)pyrene. Cancer Res. 41, 4341-4345.
38. Hey, M. M., Haaf, H., McLachlan, J. A., and Metzler, M. (1986) Indirect evidence for the metabolic dehalogenation of tetrafluorodiethylstilbestrol by rat and hamster liver and kidney microsomes. Biochem. Pharmacol. 34, 2135-2139.
39. Liehr, J. G. (1984) Modulation of estrogen-induced carcinogenesis by chemical modifications. Arch. Toxicol. 55, 119-122.
40. Liehr, J. G. (1983) 2-Fluoroestradiol: separation of estrogenicity from carcinogenicity. Mol. Pharmacol. 23, 278-281.
41. Morgan, P., Maggs, J. L., Page, P. C. B., and Park, B. K. (1992) Oxidative dehalogenation of 2-fluoro-17α-ethynyloestradiol in vivo. Biochem. Pharmacol. 44, 1717-1724.
42. Oravec, C. T., Daniel, F. B., and Wong, L. K. (1983) Comparative metabolism of 7,12-dimethylbenz[α]anthracene and its non-carcinogenic 2-fluoro analogue by Syrian hamster embryo cells. Cancer Lett. 21, 43-55.
43. Scribner, J. D., Scribner, N. K., and Koponen, G. (1982) Metabolism and nucleic acid binding of 7-fluoro-2-acetamidofluorene in rats: oxidative defluorination and apparent dissociation from hepatocarcinogenesis of 8-(N-arylamide)guanine adducts on DNA. Chem. Biol. Interact. 40, 27-43.
44. Rietjens, I. M. C. M., and Vervoort, J. (1992) A new hypothesis for the mechanism for cytochrome P450 dependent aerobic conversion of hexahalogenated benzenes to pentahalogenated phenols. Chem. Res. Toxicol. 5, 10-19.
45. Macdonald, T. L. (1983) Chemical mechanisms of halocarbon metabolism. CRC Crit. Rev. Toxicol. 11, 85-120.
46. Guengerich, F. P. (1989) Oxidation of halogenated compounds by cytochrome P-450, peroxidases, and model metalloporphyrins. J. Biol. Chem. 264, 17198-17205.
47. 14C]chlorobenzene by hepatic microsomes. J. Am. Chem. Soc. 97, 4428-4430.
48. Hanzlik, R. P., Hogberg, K., and Judson, C. M. (1984) Microsomal hydroxylation of specifically deuterated monosubstituted benzenes. Evidence for direct aromatic hydroxylation. Biochemistry 23, 3048-3055.
49. Korzekwa, K. R., Swinney, D. C., and Trager, W. F. (1989) Isotopically labeled chlorobenzenes as probes for the mechanism of cytochrome P450 catalyzed aromatic hydroxylation. Biochemistry 28, 9019-9027.
50. Rietjens, I. M. C. M., Soffers, A. E. M. F., Veeger, C., and Vervoort, J. (1993) Regioselectivity of cytochrome P450 catalyzed hydroxylation of fluorobenzenes predicted by calculated frontier orbital substrate characteristics. Biochemistry 32, 4801-4812.
51. Korzekwa, K., Trager, W., Gouterman, M., Spangler, D., and Loew, G. H. (1985) Cytochrome P450 mediated aromatic oxidation: A theoretical study. J. Am. Chem. Soc. 107, 4273-4279.
52. Guroff, G., Daly, J. W., Jerina, D. M., Renson, J., Witkop, B., and Udenfriend, S. (1967) Hydroxylation-induced migration: the NIH shift. Science 157, 1524-1530.
53. Daly, J. W., Jerina, D. M., and Witkop, B. (1972) Arene oxides and the NIH shift: the metabolism, toxicity and carcinogenicity of aromatic compounds. Experientia 28, 1129-1264.